[1] Wang X, Zhang N, Bo M, et al. Diversity of T (H) cytokine profiles in patients with chronic rhinosinusitis:a multicenter study in Europe, Asia, and Oceania[J]. J Allergy Clin Immunol, 2016,138(5):1344-1353. [2] Akdis C A, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis:a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma&Immunology[J]. J Allergy Clin Immunol,2013,131(6):1479-1490. [3] Gurrola J 2nd, Borish L. Chronic rhinosinusitis:endotypes, biomarkers, and treatment response[J]. J Allergy Clin Immunol, 2017,140(6):1499-1508. [4] Di Cesare A, Di Meglio P, Nestle F O. The IL-23/Th17 axis in the immunopathogenesis of psoriasis[J]. J Invest Dermatol, 2009, 129(6):1339-1350. [5] Girolomoni G, Strohal R, Puig L, et al.The role of IL-23 and the IL-23/T (H)17 immune axis in the pathogenesis and treatment of psoriasis[J]. J Eur Acad Dermatol Venereol,2017,31(10):1616-1626. [6] Cornelissen F, van Hamburg J P, Lubberts E. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis[J]. Curr Opin Investig Drugs, 2009, 10(5):452-462. [7] Kvedaraite E, Lourda M, Ideström M,et al. Tissue-infiltrating neutrophils represent the main source of IL-23 in the colon of patients with IBD[J]. Gut, 2016, 65(10):1632-1641. [8] Guochen D, Yahui W, Ying S I, et al. Expression of IL-23 in nasal polyps and its significance[J]. Medical Journal of the Chinese People's Armed Police Forces, 2012, 23(11):976-978. [9] Fokkens W J, Lund V J, Mullol J, et al. EPOS 2012:European position paper on rhinosinusitis and nasal polyps 2012.A summary for otorhinolaryngologists[J]. Rhinology, 2012,50(1):1-12. [10] Wang M, Wang X, Zhang N, et al. Association of periostin expression with eosinophilic inflammation in nasal polyps[J]. J Allergy Clin Immunol, 2015,136(6):1700-1703.e9. [11] Wang M, Zhang N, Zheng M, et al. Cross-talk between T (H)2 and T (H)17 pathways in patients with chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2019,144(5):1254-1264. [12] Cai X Y, Gommoll CP Jr, Justice L, et al. Regulation of granulocyte colony-stimulating factor gene expression by interleukin-17[J]. Immunol Lett, 1998,62(1):51-58. [13] Mailer R K, Joly A L, Liu S, et al. IL-1β promotes Th17 differentiation by inducing alternative splicing of FOXP3[J]. Sci Rep, 2015,5:14674. [14] Mizunoe S, Shuto T, Suzuki S, et al. Synergism between interleukin (IL)-17 and Toll-like receptor 2 and 4 signals to induce IL-8 expression in cystic fibrosis airway epithelial cells[J]. J Pharmacol Sci, 2012,118(4):512-520. [15] Li P, Yang Q Z, Wang W, et al. Increased IL-4 and IL-17-producing CD8(+) cells are related to decreased CD39(+) CD4(+) Foxp3(+) cells in allergic asthma[J]. J Asthma, 2018,55(1):8-14. [16] Halwani R, Sultana A, Vazquez-Tello A, et al.Th-17 regulatory cytokines IL-21, IL-23, and IL-6 enhance neutrophil production of IL-17 cytokines during asthma[J]. J Asthma, 2017,54(9):893-904. [17] Guerra E S, Lee C K, Specht C A, et al. Central role of IL-23 and IL-17 producing eosinophils as immunomodulatory effector cells in acute pulmonary aspergillosis and allergic asthma[J]. PLoS Pathog,2017,13(1):e1006175. [18] Roos A B, Sethi S, Nikota J, et al. IL-17A and the promotion of neutrophilia in acute exacerbation of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2015,192(4):428-437. [19] Mehrotra P, Collett J A, McKinney S D, et al. IL-17 mediates neutrophil infiltration and renal fibrosis following recovery from ischemia reperfusion:compensatory role of natural killer cells in athymic rats[J]. Am J Physiol Renal Physiol, 2017, 312(3):F385-F397. [20] McDermott A J, Falkowski N R, McDonald R A, et al. Interleukin-23(IL-23), independent of IL-17 and IL-22, drives neutrophil recruitment and innate inflammation during clostridium difficile colitis in mice[J]. Immunology, 2016,147(1):114-124. [21] Choy D F, Hart K M, Borthwick L A, et al. TH2 and TH17 inflammatory pathways are reciprocally regulated in asthma[J]. Sci Transl Med, 2015,7(301):301ra129. |